Clinical Safety and Efficacy of Ablation for Atrial Fibrillation Patients With a History of Stroke
To evaluate the clinical safety and efficacy of radiofrequency catheter ablation for atrial fibrillation patients with a history of stroke. A total of 116 symptomatic, drug-refractory AF patients with a history of stroke, and 1:2 matched patients without a history of stroke were enrolled. Of these,...
Saved in:
Published in | Frontiers in cardiovascular medicine Vol. 8; p. 630090 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
10.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To evaluate the clinical safety and efficacy of radiofrequency catheter ablation for atrial fibrillation patients with a history of stroke.
A total of 116 symptomatic, drug-refractory AF patients with a history of stroke, and 1:2 matched patients without a history of stroke were enrolled. Of these, 28 cases occurred stroke within 3 months (Group 1), 88 cases with stroke history longer than 3 months (Group 2), and 232 cases without stroke (Group 3). PVI was performed in all patients, extended to ablation of linear lesions ablation. The periprocedural stroke rates and other procedure-related in-hospital complications did not differ significantly among the three groups. The maintenance rate of SR after the procedure showed no significant difference (
= 0.333), 52.7, 66.4, and 70.7% in Group 1, 2, and 3, respectively. Furthermore, the comparison between a history of stroke and those without it were also shown no significant difference (
= 0.351).
Radiofrequency ablation for AF patients occurred stroke, even within 3 months is safe and effective, without higher periprocedural complication rate and recurrence rate. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Cardiac Rhythmology, a section of the journal Frontiers in Cardiovascular Medicine These authors have contributed equally to this work Reviewed by: Osmar Antonio Centurion, National University of Asunción, Paraguay; Martin Ibarrola, Independent Researcher, Bella Vista, Argentina Edited by: Shimon Rosenheck, Hebrew University of Jerusalem, Israel |
ISSN: | 2297-055X 2297-055X |
DOI: | 10.3389/fcvm.2021.630090 |